DRKS00030673招募中不适用
Clinical outcomes of AcrySof IQ Vivity intraocular lens in patients with age-related macular degeneration after cataract surgery - VIVITY DMAE
Promoter's representative of OFTALVIST (Oftalmología Vistahermosa, SL)0 个研究点目标入组 25 人开始时间: 2023年5月24日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 50 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1. Patients undergoing cataract surgery.
- •2. Early AMD with low or medium risk of progression according to NICE guidelines.
- •3. Age range of patients between 50 and 80 years.
排除标准
- •1. Intermediate or advanced AMD
- •2. Other potential ocular alterations
- •3. Previous ocular surgeries
- •4. Patients with missing information or missing data will be discarded from the analysis.
研究者
相似试验
已完成
不适用
Visual Outcomes of Vivity in Patients With High Axial LengthCataractNCT05210569Dr. James J. Wiens Medical Corporation20
已完成
不适用
AcrySof Toric Clinical ResultsCataractsAstigmatismNCT01214863Alcon Research144
已完成
不适用
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00CataractNCT02529488Alcon Research167
已完成
不适用
A Clinical Outcome Study of Two Multifocal Intraocular Lenses (IOL) in Cataract PatientsCataractsNCT01684007Alcon Research112
已完成
不适用
Assessment of an intraocular lens to provide independence from optical aids at all distances following cataract surgery in patients with astigmatism.CataractACTRN12619001109190Alcon Laboratories12